Authors:
Babiker, A
Darbyshire, N
Pezzotti, P
Porter, K
Rezza, G
Walker, S
Beral, V
Coutinho, R
Del Amo, J
Gill, N
Lee, C
Meyer, L
Tyrer, F
Dabis, F
Thiebaut, R
Lawson-Ayayi, S
Meyer, L
Boufassa, F
Hamouda, O
Lorenzo, JI
Touloumi, G
Hatzakis, A
Karafoulidou, A
Katsarou, O
Brettle, R
del Romero, J
Prins, M
Coutinho, RA
van Benthem, B
Coutinho, RA
Kirk, O
Pedersen, C
Aguado, IH
Perez-Hoyos, S
Eskild, A
Bruun, JN
Sannes, M
Sabin, C
Johnson, AM
Phillips, AN
Darbyshire, JH
Francioli, P
Vanhems, P
Egger, M
Rickenbach, M
Cooper, D
Kaldor, J
Vizzard, J
Tusell, JM
Ruiz, I
Cayla, JA
de Olalla, PG
Day, NE
De Angelis, D
Citation: A. Babiker et al., Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?, J ACQ IMM D, 28(2), 2001, pp. 158-165
Authors:
Kirk, O
Glenthoj, J
Dragsted, UB
Helweg-Larsen, J
Aru, TM
Benfield, TL
Jensen, K
Vestbo, J
Lundgren, JD
Citation: O. Kirk et al., Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital, DAN MED B, 48(2), 2001, pp. 84-88
Authors:
Kirk, O
Mocroft, A
Pradier, C
Bruun, JN
Hemmer, R
Clotet, B
Miller, V
Viard, JP
Phillips, AN
Lundgren, JD
Citation: O. Kirk et al., Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir, AIDS, 15(8), 2001, pp. 999-1008
Authors:
Phillips, AN
Staszewski, S
Weber, R
Kirk, O
Francioli, P
Miller, V
Vernazza, P
Lundgren, JD
Ledergerber, B
Citation: An. Phillips et al., HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load, J AM MED A, 286(20), 2001, pp. 2560-2567
Authors:
Ledergerber, B
Mocroft, A
Reiss, P
Furrer, H
Kirk, O
Bickel, M
Uberti-Foppa, C
Pradier, C
Monforte, AD
Schneider, MME
Lundgren, JD
Citation: B. Ledergerber et al., Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy., N ENG J MED, 344(3), 2001, pp. 168-174
Authors:
Viard, JP
Mocroft, A
Chiesi, A
Kirk, O
Roge, B
Panos, G
Vetter, N
Bruun, JN
Johnson, M
Lundgren, JD
Citation: Jp. Viard et al., Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence fromthe EuroSIDA study, J INFEC DIS, 183(8), 2001, pp. 1290-1294
Authors:
Kirk, O
Pedersen, C
Cozzi-Lepri, A
Antunes, F
Miller, V
Gatell, JM
Katlama, C
Lazzarin, A
Skinhoj, P
Barton, SE
Citation: O. Kirk et al., Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy, BLOOD, 98(12), 2001, pp. 3406-3412
Authors:
Kirk, O
Gatell, JM
Mocroft, A
Pedersen, C
Proenca, R
Brettle, RP
Barton, SE
Sudre, P
Phillips, AN
Lundgren, JD
Citation: O. Kirk et al., Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviraltherapy, AM J R CRIT, 162(3), 2000, pp. 865-872
Authors:
Hansen, PB
Penkowa, M
Kirk, O
Skinhoj, P
Pedersen, C
Lisse, I
Kiss, K
Zhou, XG
Hamilton-Dutoit, SJ
Citation: Pb. Hansen et al., Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990 to 1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8, EUR J HAEMA, 64(6), 2000, pp. 368-375
Authors:
Porter, K
Babiker, A
Walker, S
Darbyshire, J
Gill, N
Beral, V
Coutinho, R
Darbyshire, J
Gill, N
Lee, C
Meyer, L
Rezza, G
Porter, K
Babiker, A
Walker, S
Darbyshire, J
Tyrer, F
Dabis, F
Marimoutou, C
Meyer, L
Boufassa, F
Hamouda, O
Brunn, M
Pezzotti, P
Rezza, G
Lorenzo, JI
Touloumi, G
Hatzakis, A
Karafoulidou, A
Katsarou, O
Brettle, R
Del Amo, J
del Romero, J
Prins, M
Coutinho, RA
van Benthem, B
Coutinho, RA
Kirk, O
Pedersen, C
AGuado, IH
Perez-Hoyos, S
Eskild, A
Bruun, JN
Sannes, M
Sabin, C
Lee, C
Johnson, AM
Phillips, AN
Babiker, A
Darbyshire, JH
Gill, N
Porter, K
Egger, M
Francioli, P
Rickenbach, M
Cooper, D
Kaldor, J
Cooper, D
Kaldor, J
Vizzard, J
Tusell, JM
Ruiz, I
Cayla, JA
de Olalla, PG
Day, NE
De Angelis, D
Citation: K. Porter et al., Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE, AIDS, 14(13), 2000, pp. 1899-1906
Authors:
Babiker, A
Darby, S
De Angelis, D
Kwart, D
Porter, K
Beral, V
Darbyshire, J
Day, N
Gill, N
Coutinho, R
Prins, M
van Benthem, B
Coutinho, R
Dabis, F
Marimoutou, C
Ruiz, I
Tusell, J
Altisent, C
Evatt, B
Jaffe, H
Kirk, O
Pedersen, C
Rosenberg, P
Goedert, J
Biggar, R
Melbye, M
Brettie, R
Downs, A
Hamouda, O
Touloumi, G
Karafoulidou, A
Katsarou, O
Donfield, S
Gomperts, E
Hilgartner, M
Hoots, K
Schoenbaum, E
Beral, V
Zangerle, R
Del Amo, J
Pezzotti, P
Rezza, G
Hutchinson, S
Day, N
De Angelis, D
Gore, S
Kingsley, L
Schrager, L
Rosenberg, P
Goedert, J
Melnick, S
Koblin, B
Eskild, A
Bruun, J
Sannes, M
Evans, B
Lepri, AC
Sabin, C
Buchbinder, S
Vittinghoff, E
Moss, A
Osmond, D
Winkelstein, W
Goldberg, D
Boufassa, F
Meyer, L
Egger, M
Francioli, P
Rickenbach, M
Cooper, D
Tindall, B
Sharkey, T
Vizzard, J
Kaldor, J
Cunningham, P
Vanhems, P
Vizzard, J
Kaldor, J
Learmont, J
Farewell, V
Berglund, O
Mosley, J
Operskalski, E
van den Berg, M
Metzger, D
Tobin, D
Woody, G
Rusnak, J
Hendrix, C
Garner, R
Hawkes, C
Renzullo, P
Garland, F
Darby, S
Ewart, D
Giangrande, P
Lee, C
Phillips, A
Spooner, R
Wilde, J
Winter, M
Babiker, A
Darbyshire, J
Evans, B
Gill, N
Johnson, A
Phillips, A
Porter, K
Lorenzo, JI
Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Authors:
Katzenstein, TL
Kirk, O
Pedersen, C
Lundgren, JD
Nielsen, H
Obel, N
Nielsen, C
Mathiesen, LR
Gerstoft, J
Citation: Tl. Katzenstein et al., The Danish protease inhibitor study: A randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection, J INFEC DIS, 182(3), 2000, pp. 744-750
Authors:
Paredes, R
Mocroft, A
Kirk, O
Lazzarin, A
Barton, SE
van Lunzen, J
Katzenstein, TL
Antunes, F
Lundgren, JD
Clotet, B
Citation: R. Paredes et al., Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe - Results fromthe EuroSIDA Study, ARCH IN MED, 160(8), 2000, pp. 1123-1132
Authors:
Mocroft, A
Kirk, O
Barton, SE
Dietrich, M
Proenca, R
Colebunders, R
Pradier, C
Monforte, AD
Ledergerber, B
Lundgren, JD
Citation: A. Mocroft et al., Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe, AIDS, 13(8), 1999, pp. 943-950
Authors:
Kirk, O
Lundgren, JD
Pedersen, C
Nielsen, H
Gerstoft, J
Citation: O. Kirk et al., Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?, AIDS, 13(13), 1999, pp. 1647-1651
Authors:
Kirk, O
Katzenstein, TL
Gerstoft, J
Mathiesen, L
Nielsen, H
Pedersen, C
Lundgren, JD
Citation: O. Kirk et al., Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial, AIDS, 13(1), 1999, pp. F9-F16
Authors:
Weverling, GJ
Mocroft, A
Ledergerber, B
Kirk, O
Gonzalez-Lahoz, J
Monforte, AD
Proenca, R
Phillips, AN
Lundgren, JD
Reiss, P
Citation: Gj. Weverling et al., Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection, LANCET, 353(9161), 1999, pp. 1293-1298
Authors:
Jensen-Fangel, S
Kirk, O
Larsen, L
Blaxhult, A
Gerstoft, J
Pedersen, C
Black, FT
Lundgren, JD
Obel, N
Citation: S. Jensen-fangel et al., Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: A retrospective cohort study, SC J IN DIS, 31(5), 1999, pp. 489-493
Citation: Tb. Nielsen et al., Lipases A and B from the yeast Candida antarctica, BIOTECHNOLOGICAL APPLICATIONS OF COLD-ADAPTED ORGANISMS, 1999, pp. 49-61
Authors:
Benfield, TL
Kirk, O
Elbrond, B
Pedersen, C
Citation: Tl. Benfield et al., Complete histological regression of Kaposi's sarcoma following treatment with protease inhibitors despite persistence of HHV-8 in lesions, SC J IN DIS, 30(6), 1998, pp. 613-615